Press Releases
All Releases
Apr 04, 2024
AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
Apr 04, 2024
AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE
Apr 01, 2024
AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
Mar 19, 2024
AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
Mar 06, 2024
AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
Feb 15, 2024
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
Jan 23, 2024
AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease
Jan 05, 2024
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
Dec 21, 2023
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
Dec 07, 2023
AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024
Dec 07, 2023
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism
Oct 04, 2023
AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
Sep 12, 2023
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
Aug 15, 2023
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
Aug 03, 2023
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
Jul 31, 2023
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
Jul 24, 2023
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
Jul 12, 2023
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
Jun 20, 2023
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
Jun 08, 2023
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
Displaying 1 - 20 of 731